Literature DB >> 25741792

Epigenetic considerations of the APOE gene. [corrected].

Chang-En Yu, Jessica Foraker.   

Abstract

The apolipoprotein E (APOE) gene is robustly linked with numerous physiological conditions, including healthy aging, altered cardiovascular fitness, and cognitive function. These connections have been established primarily by phenotype-genotype association studies using APOE's three common genetic variants (ε2, ε3, and ε4). These variants encode for the three apoE protein isoforms (E2, E3, and E4), which have slightly different structures and, consequently, distinct functions in lipid metabolism. However, the differential lipid binding and transferring properties of these isoforms cannot fully explain the association of APOE with such a wide range of physiological phenotypes. One potential explanation for APOE's pleiotropic roles may lie in its unique epigenetic properties. In this article, we present a brief review of the APOE gene and protein, its disease associations, and epigenetic components, with a focus on DNA methylation. We close with a discussion of the prospective epigenetic implications of APOE in disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25741792     DOI: 10.1515/bmc-2014-0039

Source DB:  PubMed          Journal:  Biomol Concepts        ISSN: 1868-5021


  8 in total

Review 1.  Cell-specific production, secretion, and function of apolipoprotein E.

Authors:  Maaike Kockx; Mathew Traini; Leonard Kritharides
Journal:  J Mol Med (Berl)       Date:  2018-03-07       Impact factor: 4.599

Review 2.  ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias.

Authors:  Yuka A Martens; Na Zhao; Chia-Chen Liu; Takahisa Kanekiyo; Austin J Yang; Alison M Goate; David M Holtzman; Guojun Bu
Journal:  Neuron       Date:  2022-03-16       Impact factor: 18.688

3.  Association of DNA methylation and genetic variations of the APOE gene with the risk of diabetic dyslipidemia.

Authors:  Suheir Ereqat; Stéphane Cauchi; Khaled Eweidat; Muawiyah Elqadi; Manal Ghatass; Anas Sabarneh; Abedelmajeed Nasereddin
Journal:  Biomed Rep       Date:  2022-05-27

4.  APOE DNA methylation is altered in Lewy body dementia.

Authors:  Jessica Tulloch; Lesley Leong; Sunny Chen; C Dirk Keene; Steven P Millard; Andrew Shutes-David; Oscar L Lopez; Julia Kofler; Jeffrey A Kaye; Randy Woltjer; Peter T Nelson; Janna H Neltner; Gregory A Jicha; Douglas Galasko; Eliezer Masliah; James B Leverenz; Chang-En Yu; Debby Tsuang
Journal:  Alzheimers Dement       Date:  2018-03-12       Impact factor: 21.566

5.  The synergistic risk effect of apolipoprotein ε4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer's disease.

Authors:  Cíntia Monique Boschmann Ens de Bem; Julio Carlos Pezzi; Ericksen Mielle Borba; Marcia Lorena Fagundes Chaves; Fabiana Michelsen de Andrade; Marilu Fiegenbaum; Analuiza Camozzato
Journal:  Mol Biol Rep       Date:  2016-05-17       Impact factor: 2.316

6.  Glia-specific APOE epigenetic changes in the Alzheimer's disease brain.

Authors:  Jessica Tulloch; Lesley Leong; Zachary Thomson; Sunny Chen; Eun-Gyung Lee; C Dirk Keene; Steven P Millard; Chang-En Yu
Journal:  Brain Res       Date:  2018-08-03       Impact factor: 3.252

Review 7.  Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for Therapy.

Authors:  Aintzane Urbizu; Katrin Beyer
Journal:  Int J Mol Sci       Date:  2020-07-02       Impact factor: 5.923

8.  Haplotype analysis of APOE intragenic SNPs.

Authors:  Vladimir N Babenko; Dmitry A Afonnikov; Elena V Ignatieva; Anton V Klimov; Fedor E Gusev; Evgeny I Rogaev
Journal:  BMC Neurosci       Date:  2018-04-19       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.